Lab and medical centre play Clearbridge to be listed, led by former Cordlife CEO Yee

Benjamin Cher
Benjamin Cher12/18/2017 8:0 AM GMT+08  • 5 min read
Lab and medical centre play Clearbridge to be listed, led by former Cordlife CEO Yee
SINGAPORE (Dec 18): Former Cordlife Group CEO Jeremy Yee is making a comeback via Clearbridge Health, a healthcare company seeking a listing on the Singapore Exchange’s Catalist board. Clearbridge aims to raise $24.6 million by issuing 88 million shares
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Dec 18): Former Cordlife Group CEO Jeremy Yee is making a comeback via Clearbridge Health, a healthcare company seeking a listing on the Singapore Exchange’s Catalist board. Clearbridge aims to raise $24.6 million by issuing 88 million shares at 28 cents each. The issue shares represent 18.3% of the enlarged share capital of 481 million shares, which puts the company’s post-invitation market cap at $134.7 million.

Post-IPO, Clearbridge’s single-largest shareholders will be Johnson Chen (with 15.7%) and an entity known as QED Innovate (with almost 24%). QED Innovate’s shareholders include Halcyon Investment Capital (27.3%) and Tri3 Capital (12.6%). Yee owns 7.2% of Halcyon. He and his wife, Leong Wee Lee, jointly own 100% of Tri3. Chen is non-executive and non-independent chairman of Clearbridge; Yee is its executive director and CEO.

Clearbridge had started out in 2010 running an accelerator programme to incubate and accelerate healthcare, info-security and technology start-ups. The accelerator managed a $40 million fund to invest in life-sciences companies under the SPRING Singapore Biomedical Sciences Accelerator (BSA) programme.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.